Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
This grant funds initial translational efforts for neurotherapeutic agent characterization and efficacy studies.
About this program
The Innovation Grants to Nurture Initial Translational Efforts (IGNITE) program supports projects focused on the characterization of neurotherapeutic agents and their in vivo efficacy. This grant is designed for researchers and organizations involved in the early stages of drug development, particularly those working on neurotherapeutics. The program aims to facilitate the transition of promising therapeutic candidates from the laboratory to clinical application, enhancing the potential for successful treatment options in neurological disorders.
Eligibility
Eligible applicants include academic institutions, nonprofit organizations, and small businesses engaged in biomedical research.